Because research on real humans and real diseases is exceptionally difficult. Clinical research is notoriously expensive, results are likely to differ from non-human (preclinical) models, and trials take forever to get started, gather enough data, and get a drug actually reviewed and approved. So even when everyone is excited by the preclinical data, there are so many barriers (both scientific and non-scientific) that getting to an approved drug is pretty unlikely.
dyauspitr|1 month ago
dekhn|1 month ago
ngriffiths|1 month ago
namuol|1 month ago
I think the way a drug impacts the brain is kind of important
giardini|1 month ago
Growth of single human organs or organ tissue is easier, cheaper and less fraught with political peril.
Tade0|1 month ago
kens|1 month ago
https://www.science.org/doi/10.1126/science.adt3527
stevenwoo|1 month ago